These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. [Progressive supranuclear paralysis. A case with "apraxia of the eye opening" and favorable response to treatment with L-dopa]. Dehaene I, Bogaerts M. Acta Neurol Belg; 1971 Oct 04; 71(2):141-5. PubMed ID: 5000585 [No Abstract] [Full Text] [Related]
14. The treatment of progressive supranuclear palsy with L-dopa. Donaldson IM. Aust N Z J Med; 1973 Aug 04; 3(4):413-6. PubMed ID: 4519129 [No Abstract] [Full Text] [Related]
16. [Improvement of ophthalmoplegia by 5-hydroxytryptophan in two cases of progressive supranuclear palsy]. Yukitake M, Takashima Y, Kurohara K, Matsui M, Kuroda Y. Rinsho Shinkeigaku; 1996 Jul 04; 36(7):906-8. PubMed ID: 8952364 [Abstract] [Full Text] [Related]
17. [Progressive supranuclear paralysis. Anatomical and clinical observation]. Cambier J, Escourolle R, Masson M, Lechevalier B. Rev Neurol (Paris); 1969 Aug 04; 121(2):139-54. PubMed ID: 5378479 [No Abstract] [Full Text] [Related]
18. Progressive supranuclear palsy (the Steele-Richardson-Olszewski syndrome) clinical and electrophysiological observations in eleven cases. Mastaglia FL, Grainger K, Kee F, Sadka M, Lefroy R. Proc Aust Assoc Neurol; 1973 Aug 04; 10(0):35-44. PubMed ID: 4792160 [No Abstract] [Full Text] [Related]